Plain-English translation of NCT06479070 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is looking at a blood test that measures tiny pieces of cancer DNA floating in your bloodstream. Researchers want to see if this blood test, taken one month after you finish radiation therapy, can predict whether your cancer will stay gone for at least two years. This test may help doctors understand early on how well your treatment worked.
Right now, doctors have to wait months or years to know if radiation therapy cured your throat cancer. This study hopes to find a faster way—through a simple blood test—to predict treatment success so doctors could catch problems sooner if the cancer comes back.
You likely qualify if…
You likely don't qualify if…
You will have 12 blood samples taken over about 24 months—starting before your radiation therapy begins, then at regular intervals during treatment, one month after treatment ends, and during follow-up visits. Each blood draw is quick and routine. Researchers will measure the amount of cancer DNA in your blood to see if it decreases after treatment and whether this predicts how well you stay cancer-free.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
France